Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Thalidomide-induced psoriasis in a patient with multiple myeloma.

D'Arena G, Galdo G, Musto P.

Postgrad Med J. 2019 Feb 26. pii: postgradmedj-2018-136317. doi: 10.1136/postgradmedj-2018-136317. [Epub ahead of print] No abstract available.

PMID:
30808723
2.

Monoclonal B-cell lymphocytosis and prostate cancer: incidence and effects of radiotherapy.

D'Auria F, Valvano L, Rago L, Statuto T, Calice G, D'Arena G, Fusco V, Musto P.

J Investig Med. 2019 Jan 11. pii: jim-2018-000902. doi: 10.1136/jim-2018-000902. [Epub ahead of print]

PMID:
30635362
3.

Clinical Pharmacology of Citrus aurantium and Citrus sinensis for the Treatment of Anxiety.

Mannucci C, Calapai F, Cardia L, Inferrera G, D'Arena G, Di Pietro M, Navarra M, Gangemi S, Ventura Spagnolo E, Calapai G.

Evid Based Complement Alternat Med. 2018 Dec 2;2018:3624094. doi: 10.1155/2018/3624094. eCollection 2018. Review.

4.

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).

Musto P, Simeon V, Cascavilla N, Falcone A, Petrucci MT, Cesini L, Di Raimondo F, Conticello C, Ria R, Catalano L, Salvatore D, Mastrullo L, Gagliardi A, Villani O, Pietrantuono G, D'Arena G, Mansueto G, Bringhen S, Genuardi M, Di Renzo N, Reddiconto G, Fragasso A, Caravita T, Scapicchio D, Marziano G, Boccadoro M, Mangiacavalli S, Corso A.

Ann Hematol. 2019 Feb;98(2):361-367. doi: 10.1007/s00277-018-3524-1. Epub 2018 Oct 23.

PMID:
30353388
5.

Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.

D'Arena G, Seneca E, Migliaccio I, De Feo V, Giudice A, La Rocca F, Capunzo M, Calapai G, Festa A, Caraglia M, Musto P, Iorio EL, Ruggieri V.

Leuk Lymphoma. 2018 Sep 20:1-9. doi: 10.1080/10428194.2018.1509317. [Epub ahead of print]

PMID:
30234409
6.

External validation of the accuracy of 'CLLflow score'.

D'Arena G, Vitale C, Coscia M, D'Auria F, Bellesi S, Topini G, Panichi V, Valvano L, Statuto T, Corrente F, Laurenti L.

J Investig Med. 2018 Oct;66(7):e6. doi: 10.1136/jim-2018-000832. Epub 2018 Sep 14. No abstract available.

PMID:
30217834
7.

Meningeal Involvement in Primary Plasma Cell Leukemia.

D'Arena G, Bitetti C, Daraia B, Pietrantuono G, Musto P.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):556-557. doi: 10.1007/s12288-018-0943-z. Epub 2018 Mar 12. No abstract available.

PMID:
30127574
8.

The Effect of Light Exposure at Night (LAN) on Carcinogenesis via Decreased Nocturnal Melatonin Synthesis.

Giudice A, Crispo A, Grimaldi M, Polo A, Bimonte S, Capunzo M, Amore A, D'Arena G, Cerino P, Budillon A, Botti G, Costantini S, Montella M.

Molecules. 2018 May 29;23(6). pii: E1308. doi: 10.3390/molecules23061308. Review.

9.

CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.

D'Arena G, Vitale C, Rossi G, Coscia M, Omedè P, D'Auria F, Statuto T, Valvano L, Ciolli S, Gilestro M, Molica S, Bellesi S, Topini G, Panichi V, Autore F, Innocenti I, Musto P, Deaglio S, Laurenti L, Del Vecchio L.

Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2510. [Epub ahead of print]

PMID:
29602219
10.

Pseudomembranous colitis in acute lymphoblastic leukaemia.

D'Arena G, Pietrantuono G, Musto P.

Postgrad Med J. 2018 Jun;94(1112):361. doi: 10.1136/postgradmedj-2018-135605. Epub 2018 Mar 2. No abstract available.

PMID:
29500180
11.

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

D'Arena G, Vitale C, Coscia M, Festa A, Di Minno NMD, De Feo V, Caraglia M, Calapai G, Laurenti L, Musto P, Di Minno G, Fenoglio D.

J Immunol Res. 2017;2017:1832968. doi: 10.1155/2017/1832968. Epub 2017 Dec 21. Review.

12.

Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer.

Giudice A, Montella M, Boccellino M, Crispo A, D'Arena G, Bimonte S, Facchini G, Ciliberto G, Botti G, Quagliuolo L, Caraglia M, Capunzo M.

Curr Mol Med. 2017;17(6):405-420. doi: 10.2174/1566524018666171219101937.

PMID:
29256350
13.

Unusual Hypergranular Myelomatous Plasma Cells.

D'Arena G, Musto P.

Indian J Hematol Blood Transfus. 2017 Dec;33(4):617-618. doi: 10.1007/s12288-017-0786-z. Epub 2017 Jan 30. No abstract available.

14.

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

Bulian P, Bomben R, Bo MD, Zucchetto A, Rossi FM, Degan M, Pozzo F, Bittolo T, Bravin V, D'Agaro T, Cerri M, Chiarenza A, Chaffee KG, Condoluci A, D'Arena G, Spina M, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Poeta GD, Gaidano G, Shanafelt TD, Gattei V.

Haematologica. 2017 Nov;102(11):e443-e446. doi: 10.3324/haematol.2017.170340. Epub 2017 Jul 27. No abstract available.

15.

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

D'Agaro T, Bittolo T, Bravin V, Dal Bo M, Pozzo F, Bulian P, Rossi FM, Zucchetto A, Degan M, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Gaidano G, Del Poeta G, Gattei V, Bomben R.

Br J Haematol. 2018 Aug;182(4):597-602. doi: 10.1111/bjh.14843. Epub 2017 Jul 12. No abstract available.

PMID:
28699643
16.

Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia.

D'Arena G, Vitale C, Perbellini O, Coscia M, La Rocca F, Ruggieri V, Visco C, Di Minno NMD, Innocenti I, Pizza V, Deaglio S, Di Minno G, Giudice A, Calapai G, Musto P, Laurenti L, Iorio EL.

Eur J Haematol. 2017 Oct;99(4):306-314. doi: 10.1111/ejh.12918. Epub 2017 Aug 3.

PMID:
28646624
17.

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.

Laurenti L, Innocenti I, Autore F, Ciolli S, Mauro FR, Mannina D, Del Poeta G, D'Arena G, Massaia M, Coscia M, Molica S, Pozzato G, Efremov DG, Vannata B, Marasca R, Galieni P, Cuneo A, Orlando S, Piciocchi A, Boncompagni R, Vincelli D, Liberati AM, Russo F, Foá R.

Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8. No abstract available.

18.

Mutations in the 3' untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia.

Bittolo T, Pozzo F, Bomben R, D'Agaro T, Bravin V, Bulian P, Rossi FM, Zucchetto A, Degan M, Macor P, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Di Raimondo F, Rossi D, Gaidano G, Del Poeta G, Gattei V, Dal Bo M.

Haematologica. 2017 Aug;102(8):e305-e309. doi: 10.3324/haematol.2016.162594. Epub 2017 May 26. No abstract available.

19.

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

D'Auria F, La Rocca F, Simeon V, Statuto T, Pietrantuono G, D'Arena G, Villani O, Mansueto G, Traficante A, Musto P.

Br J Haematol. 2018 May;181(4):550-552. doi: 10.1111/bjh.14662. Epub 2017 Apr 25. No abstract available.

PMID:
28439880
20.

Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.

D'Arena G, Simeon V, Laurenti L, Cimminiello M, Innocenti I, Gilio M, Padula A, Vigliotti ML, De Lorenzo S, Loseto G, Passarelli A, Di Minno MND, Tucci M, De Feo V, D'Auria F, Silvestris F, Di Minno G, Musto P.

Leuk Lymphoma. 2017 Nov;58(11):2633-2641. doi: 10.1080/10428194.2017.1306648. Epub 2017 Apr 3.

PMID:
28367662
21.

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.

Pozzo F, Bittolo T, Vendramini E, Bomben R, Bulian P, Rossi FM, Zucchetto A, Tissino E, Degan M, D'Arena G, Di Raimondo F, Zaja F, Pozzato G, Rossi D, Gaidano G, Del Poeta G, Gattei V, Dal Bo M.

Leukemia. 2017 Nov;31(11):2407-2415. doi: 10.1038/leu.2017.90. Epub 2017 Mar 21.

PMID:
28321119
22.

MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

Caivano A, La Rocca F, Simeon V, Girasole M, Dinarelli S, Laurenzana I, De Stradis A, De Luca L, Trino S, Traficante A, D'Arena G, Mansueto G, Villani O, Pietrantuono G, Laurenti L, Del Vecchio L, Musto P.

Cell Oncol (Dordr). 2017 Feb;40(1):97-103. doi: 10.1007/s13402-016-0300-x. Epub 2016 Oct 19.

PMID:
27761889
23.

Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.

De Luca L, D'Arena G, Simeon V, Trino S, Laurenzana I, Caivano A, La Rocca F, Villani O, Mansueto G, Deaglio S, Innocenti I, Laurenti L, Molica S, Pietrantuono G, De Stradis A, Del Vecchio L, Musto P.

Leuk Lymphoma. 2017 Jun;58(6):1424-1432. doi: 10.1080/10428194.2016.1243790. Epub 2016 Oct 14.

PMID:
27739922
24.

Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.

D'Arena G, Rossi G, Laurenti L, Statuto T, D'Auria F, Valvano L, Simeon V, Giudice A, Innocenti I, De Feo V, Filosa R, Musto P.

J Immunol Res. 2016;2016:9271469. doi: 10.1155/2016/9271469. Epub 2016 Jul 14.

25.

Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis.

Giudice A, D'Arena G, Crispo A, Tecce MF, Nocerino F, Grimaldi M, Rotondo E, D'Ursi AM, Scrima M, Galdiero M, Ciliberto G, Capunzo M, Franci G, Barbieri A, Bimonte S, Montella M.

Oxid Med Cell Longev. 2016;2016:6021934. doi: 10.1155/2016/6021934. Epub 2016 Feb 10. Review.

26.

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience.

Laurenti L, Autore F, Innocenti I, D'Arena G, Coscia M, Mondello P, Chiusolo P, Bellesi S, Efremov DG, Sica S, Mauro FR.

Leuk Lymphoma. 2016 Oct;57(10):2429-31. doi: 10.3109/10428194.2015.1137293. Epub 2016 Jan 27. No abstract available.

PMID:
26818825
27.

Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.

Molica S, Digiesi G, D'Arena G, Mirabelli R, Antenucci A, Conti L, Gentile M, Musto P, Neri A, Morabito F.

Br J Haematol. 2016 Dec;175(5):983-985. doi: 10.1111/bjh.13907. Epub 2016 Jan 5. No abstract available.

PMID:
26728120
28.

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.

Bologna C, Buonincontri R, Serra S, Vaisitti T, Audrito V, Brusa D, Pagnani A, Coscia M, D'Arena G, Mereu E, Piva R, Furman RR, Rossi D, Gaidano G, Terhorst C, Deaglio S.

J Clin Invest. 2016 Jan;126(1):181-94. doi: 10.1172/JCI83013. Epub 2015 Nov 30.

29.

The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

D'arena G, Grandone E, Di Minno MN, Musto P, Di Minno G.

Blood Transfus. 2016 May;14(2):255-61. doi: 10.2450/2015.0090-15. Epub 2015 Sep 3. Review.

30.

Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D'Ursi AM, Tecce MF, Amore A, Galdiero M, Ciliberto G, Giudice A.

Int J Endocrinol. 2015;2015:854530. doi: 10.1155/2015/854530. Epub 2015 Sep 27. Review.

31.

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.

Laurenti L, Innocenti I, Autore F, Vannata B, Efremov DG, Ciolli S, Del Poeta G, Mauro FR, Cortelezzi A, Borza PA, Ghio F, Mondello P, Murru R, Gozzetti A, Cariccio MR, Piccirillo N, Boncompagni R, Cantonetti M, Principe MI, Reda G, Bongarzoni V, Cervetti G, Pitini V, Foà R, Sica S, D'Arena G.

Leuk Res. 2015 Oct;39(10):1066-70. doi: 10.1016/j.leukres.2015.07.009. Epub 2015 Jul 26.

PMID:
26307523
32.

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Pozzo F, Bittolo T, Arruga F, Bulian P, Macor P, Tissino E, Gizdic B, Rossi FM, Bomben R, Zucchetto A, Benedetti D, Degan M, D'Arena G, Chiarenza A, Zaja F, Pozzato G, Rossi D, Gaidano G, Del Poeta G, Deaglio S, Gattei V, Dal Bo M.

Leukemia. 2016 Jan;30(1):182-9. doi: 10.1038/leu.2015.182. Epub 2015 Jul 13.

PMID:
26165233
33.

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Caivano A, Laurenzana I, De Luca L, La Rocca F, Simeon V, Trino S, D'Auria F, Traficante A, Maietti M, Izzo T, D'Arena G, Mansueto G, Pietrantuono G, Laurenti L, Musto P, Del Vecchio L.

Tumour Biol. 2015 Dec;36(12):9739-52. doi: 10.1007/s13277-015-3741-3. Epub 2015 Jul 9.

PMID:
26156801
34.

Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study.

Musto P, Simeon V, Grossi A, Gay F, Bringhen S, Larocca A, Guariglia R, Pietrantuono G, Villani O, D'Arena G, Cuomo C, Musto C, Morabito F, Petrucci MT, Offidani M, Zamagni E, Tacchetti P, Conticello C, Milone G, Palumbo A, Cavo M, Boccadoro M.

Stem Cell Res Ther. 2015 Apr 17;6:64. doi: 10.1186/s13287-015-0033-1.

35.

Acquired hemophilia a successfully treated with rituximab.

D'Arena G, Grandone E, Di Minno MN, Musto P, Di Minno G.

Mediterr J Hematol Infect Dis. 2015 Mar 1;7(1):e2015024. doi: 10.4084/MJHID.2015.024. eCollection 2015.

36.

Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells.

D'Arena G, Ruggieri V, D'Auria F, La Rocca F, Simeon V, Statuto T, Caivano A, Telesca D, Del Vecchio L, Musto P.

Leuk Lymphoma. 2015;56(8):2458-9. doi: 10.3109/10428194.2014.999329. Epub 2015 Jan 29. No abstract available.

PMID:
25547653
37.

Darier sign and cutaneous involvement in mastocytosis.

D'Arena G, Vita G, Musto P.

Br J Haematol. 2014 Nov;167(4):440. doi: 10.1111/bjh.13075. Epub 2014 Aug 28. No abstract available.

PMID:
25164313
38.

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy.

Musto P, Simeon V, Guariglia R, Bianchino G, Grieco V, Nozza F, La Rocca F, Marziano G, Lalinga AV, Fabiani E, Voso MT, Scaravaglio P, Mecucci C, D'Arena G.

Onco Targets Ther. 2014 Jun 13;7:1043-50. doi: 10.2147/OTT.S59628. eCollection 2014. Review.

39.

Alemtuzumab and treatment of chronic lymphocytic leukemia and its immune-related disorders: one player on two tables.

D'Arena G, Laurenti L.

Acta Haematol. 2014;132(2):237-9. No abstract available.

PMID:
24853680
40.

Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498.

D'Arena G, Calapai G, Deaglio S.

Expert Opin Ther Pat. 2014 Jul;24(7):821-8. doi: 10.1517/13543776.2014.915942. Epub 2014 May 6. Review.

PMID:
24798704
41.

Monoclonal B-cell lymphocytosis.

D'Arena G, Musto P.

Transl Med UniSa. 2014 Feb 4;8:75-9. eCollection 2014 Jan.

42.

Metabolic syndrome, insulin resistance, circadian disruption, antioxidants and pancreatic carcinoma: an overview.

Giudice A, Crispo A, Massimiliano G, D'Arena G, Tecce MF, Grimaldi M, Amore A, Esposito E, Montella M.

J Gastrointestin Liver Dis. 2014 Mar;23(1):73-7. Review.

43.

Fournier's gangrene complicating thrombocytopenia treated with steroids.

D'Arena G, Cammarota A, Musto P.

Lancet. 2014 May 3;383(9928):1580. doi: 10.1016/S0140-6736(13)61098-3. Epub 2014 Mar 14. No abstract available.

PMID:
24631163
44.

Fournier's Gangrene Complicating Hematologic Malignancies: a Case Report and Review of Licterature.

D'Arena G, Pietrantuono G, Buccino E, Pacifico G, Musto P.

Mediterr J Hematol Infect Dis. 2013 Nov 1;5(1):e2013067. doi: 10.4084/MJHID.2013.067. eCollection 2013.

45.

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Rizzo R, Audrito V, Vacca P, Rossi D, Brusa D, Stignani M, Bortolotti D, D'Arena G, Coscia M, Laurenti L, Forconi F, Gaidano G, Mingari MC, Moretta L, Malavasi F, Deaglio S.

Haematologica. 2014 May;99(5):888-96. doi: 10.3324/haematol.2013.095281. Epub 2013 Dec 20.

46.

Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.

De Padua L, Laurenti L, Falcucci P, D'arena G, Vannata B, Innocenti I, Autore F, Piccirillo N, Za T, Marietti S, Efremov DG, Sica S.

Ann Hematol. 2014 Jul;93(7):1261-2. doi: 10.1007/s00277-013-1968-x. Epub 2013 Dec 5. No abstract available.

PMID:
24306088
47.

Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.

Arruga F, Gizdic B, Serra S, Vaisitti T, Ciardullo C, Coscia M, Laurenti L, D'Arena G, Jaksic O, Inghirami G, Rossi D, Gaidano G, Deaglio S.

Leukemia. 2014 May;28(5):1060-70. doi: 10.1038/leu.2013.319. Epub 2013 Oct 30.

PMID:
24170027
48.

More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.

D'Arena G, Guariglia R, Pietrantuono G, Villani O, Martorelli MC, Mansueto G, Criscuolo C, Pierri T, Musto C, Musto P.

Leuk Lymphoma. 2014 Aug;55(8):1955-7. doi: 10.3109/10428194.2013.858151. Epub 2014 Feb 14. No abstract available.

PMID:
24152050
49.

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.

Zucchetto A, Caldana C, Benedetti D, Tissino E, Rossi FM, Hutterer E, Pozzo F, Bomben R, Dal Bo M, D'Arena G, Zaja F, Pozzato G, Di Raimondo F, Hartmann TN, Rossi D, Gaidano G, Del Poeta G, Gattei V.

Blood. 2013 Nov 7;122(19):3317-21. doi: 10.1182/blood-2013-06-507335. Epub 2013 Sep 25.

50.

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.

Musto P, Simeon V, Martorelli MC, Petrucci MT, Cascavilla N, Di Raimondo F, Caravita T, Morabito F, Offidani M, Olivieri A, Benevolo G, Mina R, Guariglia R, D'Arena G, Mansueto G, Filardi N, Nobile F, Levi A, Falcone A, Cavalli M, Pietrantuono G, Villani O, Bringhen S, Omedè P, Lerose R, Agnelli L, Todoerti K, Neri A, Boccadoro M, Palumbo A.

Leukemia. 2014 Jan;28(1):222-5. doi: 10.1038/leu.2013.241. Epub 2013 Aug 20. No abstract available.

PMID:
23958922

Supplemental Content

Loading ...
Support Center